Ocular Gene Therapy Trials Advance
Results of the first phase 3 trial in this field were announced.
Okogen Secures Ora to Conduct Clinical and Regulatory Development of OKG-0301 for Adenoviral Conjunctivitis
Okogen, Inc. to present at 2017 Biotech Showcase
Convertible Financing 101 for the Entrepreneur
Ophthalmic Product Development Insights
Cutting and Splicing For CRISPR Vision
How this particular type of gene editing works and a discussion of its potential uses in the future.
Noveome Initiates Phase 2 Clinical Trial of ST266 for the Treatment of Allergic Conjunctivitis
Second Disease Indication Shows Versatility of Paracrine Signaling Solution
Accommodation For the Aging Eye
Like death and taxes, presbyopia is one of life’s certainties, an inevitable companion to the aging process
Right Between Your Eyes
A look at ocular/nasal interactions and how they can affect our
pharmaceutical therapies.
Visual Function Biomarkers Needed for Dry AMD
Early detection may allow treatment, and possibly reversal. Part 2 of a two-part series.